المؤلفون: Toshiaki Takakura, Hiroaki Akamatsu, Atsushi Washioka, Eriko Murakami, Ryota Shibaki, Toshio Shimizu, Yasuhiro Koh, Nobuyuki Yamamoto

المصدر: Respirology Case Reports, Vol 12, Iss 9, Pp n/a-n/a (2024)

مصطلحات موضوعية: long‐term response, nivolumab, non–small cell lung cancer, rechallenge, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2051-3380

URL الوصول: https://doaj.org/article/0ae7b666526f4947868c9ccb401342a5

المؤلفون: Hirotaka Matsumoto, Hiroaki Akamatsu, Nobuyuki Yamamoto, Yuki Sato, Daichi Fujimoto, Yoshihiko Taniguchi, Motohiro Tamiya, Yasuhiro Koh, Junya Fukuoka, Hisashi Tanaka, Naoki Furuya, Ryota Shibaki, Tsukasa Nozawa, Akira Sano, Yuka Kitamura, Takashi Kijima, Toshihide Yokoyama, Satoru Miura, Akito Hata, Jun Sugisaka

المصدر: Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/12/2/e007987.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/6255e060953c4901b89e6055b35b9eff

المؤلفون: Eriko Murakami, Hiroaki Akamatsu, Shunsuke Teraoka, Toshiaki Takakura, Eri Takase, Masanori Tanaka, Takahiro Kaki, Yuhei Harutani, Katsuyuki Furuta, Takeya Sugimoto, Ryota Shibaki, Daichi Fujimoto, Atsushi Hayata, Yuichi Ozawa, Masanori Nakanishi, Yasuhiro Koh, Toshio Shimokawa, Nobuyuki Yamamoto

المصدر: Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)

مصطلحات موضوعية: chemotherapy, clinical cancer research, clinical trials, lung cancer, quality of life, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/936934c8acbe4ec093a80de605ccb236

المؤلفون: Daichi Fujimoto, Satoru Miura, Keisuke Tomii, Hiromitsu Sumikawa, Kenichi Yoshimura, Kazushige Wakuda, Yuko Oya, Toshihide Yokoyama, Takashi Kijima, Tetsuhiko Asao, Motohiro Tamiya, Atsushi Nakamura, Hiroshige Yoshioka, Takaaki Tokito, Shuji Murakami, Akihiro Tamiya, Hiroshi Yokouchi, Satoshi Watanabe, Ou Yamaguchi, Ryotaro Morinaga, Takayuki Jodai, Kentaro Ito, Yoshimasa Shiraishi, Yoshihito Kogure, Ryota Shibaki, Nobuyuki Yamamoto

المصدر: Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-2322

URL الوصول: https://doaj.org/article/d7954e13f28249d198db8ce843bb07a9

المؤلفون: Ryota Shibaki, Yuichi Ozawa, Susumu Noguchi, Yusuke Murakami, Eri Takase, Yuichiro Azuma, Masaru Maebeya, Takeya Sugimoto, Atsushi Hayata, Takahiro Hayakawa, Shinya Tamaki, Masanori Nakanishi, Shunsuke Teraoka, Hiroaki Akamatsu

المصدر: Cancer Medicine, Vol 11, Iss 20, Pp 3743-3750 (2022)

مصطلحات موضوعية: epidermal growth factor receptor, interstitial lung abnormalities, lung injury, non‐small cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/8ce8e7d2fc4341d99d6345df94b68b97

المؤلفون: Ryota Shibaki, Shuji Murakami, Yuki Shinno, Yuji Matsumoto, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noriko Motoi, Noboru Yamamoto, Yuichiro Ohe

المصدر: Thoracic Cancer, Vol 10, Iss 4, Pp 815-822 (2019)

مصطلحات موضوعية: Anti‐PD‐1 antibody, malignant pleural effusion, nivolumab, non‐small cell lung cancer, pembrolizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

URL الوصول: https://doaj.org/article/ddbbd7d29cf64cc8a67c93f2f4831fa6

المؤلفون: Ryota Shibaki, Hiroaki Akamatsu, Terufumi Kato, Kazumi Nishino, Morihito Okada, Tetsuya Mitsudomi, Kazushige Wakuda, Kenichi Yoshimura, Nobuyuki Yamamoto, Kazuhiko Nakagawa

المصدر: Therapeutic Advances in Medical Oncology, Vol 13 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1758-8359

URL الوصول: https://doaj.org/article/55bc6622154546069579a8fa4cba377b

المؤلفون: Hayato Kawachi, Motohiro Tamiya, Yuko Oya, Go Saito, Yoshihiko Taniguchi, Hirotaka Matsumoto, Yuki Sato, Taiichiro Otsuki, Hidekazu Suzuki, Yasushi Fukuda, Satoshi Tanaka, Yoko Tsukita, Junji Uchida, Yoshihiko Sakata, Yuki Nakatani, Ryota Shibaki, Daisuke Arai, Asuka Okada, Satoshi Hara, Koichi Takayama

المصدر: Clinical Lung Cancer; Nov2024, Vol. 25 Issue 7, p643-652, 10p

المؤلفون: Yuki Sato, Hiromitsu Sumikawa, Ryota Shibaki, Takeshi Morimoto, Yoshihiko Sakata, Yuko Oya, Motohiro Tamiya, Hidekazu Suzuki, Hirotaka Matsumoto, Takashi Yokoi, Kazuki Hashimoto, Hiroshi Kobe, Aoi Hino, Megumi Inaba, Yoko Tsukita, Hideki Ikeda, Daisuke Arai, Hirotaka Maruyama, Satoshi Hara, Shinsuke Tsumura, Shinya Sakata, Daichi Fujimoto

المصدر: Chest. 162:1188-1198

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e56f2b744764547b03aa1a48c2530678
https://doi.org/10.1016/j.chest.2022.05.035

المؤلفون: Yukiko Shimoda, Ryota Shibaki, Tatsuya Yoshida, Shuji Murakami, Masayuki Shirasawa, Masahiro Torasawa, Yuji Matsumoto, Ken Masuda, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe, Noriko Motoi

المصدر: Clinical Lung Cancer. 23:477-486

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8e06d65915500596d2461858ef2e161a
https://doi.org/10.1016/j.cllc.2022.04.001

المؤلفون: Eri Takase, Hiroaki Akamatsu, Shunsuke Teraoka, Keita Nakaguchi, Masanori Tanaka, Takahiro Kaki, Katsuyuki Furuta, Koichi Sato, Eriko Murakami, Takeya Sugimoto, Ryota Shibaki, Daichi Fujimoto, Atsushi Hayata, Nahomi Tokudome, Yuichi Ozawa, Yasuhiro Koh, Masanori Nakanishi, Kuninobu Kanai, Toshio Shimokawa, Nobuyuki Yamamoto

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::053072e04eee67e8700506ed3cf47b14
https://doi.org/10.21203/rs.3.rs-2639256/v1

المؤلفون: Hirotaka Matsumoto, Hidekazu Suzuki, Yoko Tsukita, Daisuke Arai, Satoshi Hara, Takeshi Uenami, Motohiro Tamiya, Shinsuke Tsumura, Asuka Okada, Yoshihiko Sakata, Takashi Yokoi, Hideki Ikeda, Megumi Inaba, Yuki Sato, Shinya Sakata, Hirotaka Maruyama, Hiroshi Kobe, Go Saito, Takuro Sakagami, Jun Morinaga, Ryota Shibaki, Yuko Oya

المصدر: European Journal of Cancer. 159:144-153

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Antineoplastic Agents, Metastasis, Cohort Studies, Interquartile range, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Osimertinib, Progression-free survival, Lung cancer, Aged, Retrospective Studies, Acrylamides, Aniline Compounds, business.industry, Hazard ratio, Middle Aged, medicine.disease, Progression-Free Survival, Confidence interval, Discontinuation, ErbB Receptors, Treatment Outcome, Female, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83d48a42905d426d98299719b208d6d
https://doi.org/10.1016/j.ejca.2021.09.041

المؤلفون: Katsuyuki Furuta, Daichi Fujimoto, Atsushi Matsunashi, Takeshi Morimoto, Masanori Tanaka, Ryota Shibaki, Yuri Shimada, Kazuma Nagata, Keisuke Tomii, Nobuyuki Yamamoto

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c7012a2886ac5674c8f038850e0baed8
https://doi.org/10.21203/rs.3.rs-1658658/v1

المؤلفون: Kan Yonemori, Akihiko Shimomura, Ryota Shibaki, Takafumi Koyama, Shigehisa Kitano, Ashish Suri, Yoichi Kase, Noboru Yamamoto, Shunsuke Kondo, Kenji Tamura, Shuuji Sumino, Satoru Iwasa, Jun Sato, Toshio Shimizu

المصدر: Japanese Journal of Clinical Oncology

مصطلحات موضوعية: Adult, Male, Oncology, PARP Inhibitor, Cancer Research, medicine.medical_specialty, Indazoles, pharmacokinetics, PARP, neoplasms, Cmax, Poly(ADP-ribose) Polymerase Inhibitors, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Japan, Piperidines, Pharmacokinetics, Internal medicine, medicine, AcademicSubjects/MED00300, Humans, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Adverse effect, Aged, business.industry, clinical trial, General Medicine, Drug holiday, phase I, Middle Aged, medicine.disease, Clinical trial, Tolerability, 030220 oncology & carcinogenesis, Cohort, Original Article, Female, niraparib, business, Progressive disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18367af43ef60498081f803ca6a2ea12
https://doi.org/10.1093/jjco/hyab013

المؤلفون: Yuji Matsumoto, Yuichiro Ohe, Hidehito Horinouchi, Ryota Shibaki, Shuji Murakami, Noboru Yamamoto, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Tatsuya Yoshida

المصدر: Thoracic Cancer

مصطلحات موضوعية: non‐small cell lung cancer, Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Multivariate analysis, soluble PD‐L1, Pembrolizumab, Antibodies, Monoclonal, Humanized, Gastroenterology, Programmed cell death ligand 1, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, mental disorders, medicine, Humans, Anti‐PD‐1 antibody, In patient, Lung cancer, Aged, Aged, 80 and over, biology, business.industry, Hazard ratio, Original Articles, General Medicine, PD‐L1 TPS, Middle Aged, Prognosis, medicine.disease, Survival Analysis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, biology.protein, Original Article, Female, Nivolumab, Antibody, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19fced2ae8c7ae9ecc4e68e52a492d5d
https://doi.org/10.1111/1759-7714.13721

المؤلفون: Yuri Shimada, Masanori Tanaka, Keisuke Tomii, Ryota Shibaki, Kazuma Nagata, Daichi Fujimoto, Nobuyuki Yamamoto, Atsushi Matsunashi, Katsuyuki Furuta

المصدر: ILD / DPLD of known origin.

مصطلحات موضوعية: medicine.medical_specialty, Exacerbation, business.industry, Internal medicine, medicine, Interstitial lung disease, Clinical course, medicine.disease, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a1414f9915661fe95c2de295c57f04c9
https://doi.org/10.1183/13993003.congress-2021.pa2241

المؤلفون: Nahomi Tokudome, Nobuyuki Yamamoto, Eri Takase, Atsushi Hayata, Eriko Murakami, Yuichi Ozawa, Masanori Tanaka, Ryota Shibaki, Shunsuke Teraoka, Takeya Sugimoto, Takahiro Kaki, Nao Yamagata, Jun Oyanagi, Yasuhiro Koh, Katsuyuki Furuta, Hiroaki Akamatsu, Keita Mori, Yuhei Harutani, Yuka Okuda

المصدر: The Oncologist

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, Predictive marker, Immune checkpoint inhibitor, 03 medical and health sciences, 0302 clinical medicine, Immune system, Carcinoma, Non-Small-Cell Lung, Neoplasms, Internal medicine, medicine, Humans, Prospective Studies, Adverse effect, Lung cancer, Immune Checkpoint Inhibitors, Retrospective Studies, business.industry, Hazard ratio, medicine.disease, Immuno‐Oncology, Confidence interval, 030104 developmental biology, 030220 oncology & carcinogenesis, Biomarker (medicine), business, Immune‐related adverse event

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7352b560f7a3ac0bcb3cbba9bd7b6739
https://doi.org/10.1634/theoncologist.2019-0299

المؤلفون: Ryota Shibaki, Hidehito Horinouchi, Yuji Matsumoto, Noboru Yamamoto, Yuichiro Ohe, Tatsuya Yoshida, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Masahiko Kusumoto, Yutaka Fujiwara, Nobuyuki Yamamoto

المصدر: Cancer Immunology, Immunotherapy. 69:15-22

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Immunology, behavioral disciplines and activities, Gastroenterology, Antineoplastic Agents, Immunological, Immune system, Carcinoma, Non-Small-Cell Lung, Internal medicine, Humans, Immunology and Allergy, Medicine, Diffuse alveolar damage, Lung, Aged, Retrospective Studies, Pneumonitis, Aged, 80 and over, biology, business.industry, Incidence, Incidence (epidemiology), Interstitial lung disease, Pneumonia, Middle Aged, respiratory system, medicine.disease, respiratory tract diseases, body regions, Oncology, Non small lung cancer, biology.protein, Female, Antibody, Lung Diseases, Interstitial, business, Hypersensitivity pneumonitis

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b3ad718065482b02a210c4281bdb654
https://doi.org/10.1007/s00262-019-02431-8

المؤلفون: Hidehito Horinouchi, Ryota Shibaki, Shuji Murakami, Yasushi Goto, Noboru Yamamoto, Noriko Motoi, Yuji Matsumoto, Shintaro Kanda, Yuichiro Ohe, Yutaka Fujiwara, Yuki Shinno

المصدر: Thoracic Cancer, Vol 10, Iss 4, Pp 815-822 (2019)
Thoracic Cancer

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Adult, Male, non‐small cell lung cancer, medicine.medical_specialty, Lung Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, Gastroenterology, lcsh:RC254-282, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Malignant pleural effusion, Humans, Anti‐PD‐1 antibody, malignant pleural effusion, Lung cancer, Survival analysis, Aged, Retrospective Studies, Aged, 80 and over, nivolumab, business.industry, Hazard ratio, Cancer, General Medicine, Original Articles, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Analysis, Confidence interval, Pleural Effusion, Malignant, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Original Article, pembrolizumab, Nivolumab, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45fc6ab7e017ab4578ff1f909ace617b
https://doaj.org/article/ddbbd7d29cf64cc8a67c93f2f4831fa6

المؤلفون: Yuhei Harutani, Yuichi Ozawa, Eriko Murakami, Koichi Sato, Jun Oyanagi, Hiroaki Akamatsu, Takanori Yoshikawa, Ryota Shibaki, Takeya Sugimoto, Katsuyuki Furuta, Shunsuke Teraoka, Nahomi Tokudome, Atsushi Hayata, Hiroki Ueda, Masanori Nakanishi, Yasuhiro Koh, Nobuyuki Yamamoto

المصدر: Cancer immunology, immunotherapy : CII. 71(9)

مصطلحات موضوعية: Cancer Research, Follistatin, Antineoplastic Agents, Immunological, Lung Neoplasms, Oncology, Carcinoma, Non-Small-Cell Lung, Immunology, Programmed Cell Death 1 Receptor, Biomarkers, Tumor, Immunology and Allergy, Humans, Prospective Studies, B7-H1 Antigen

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4408f16c1a3de647fb466744ec400833
https://pubmed.ncbi.nlm.nih.gov/35037070